Strong single-agent and PD-1/PD-L1 combination antitumor activity of antisense oligonucleotides suppressing Neuropilin 1 expression.

被引：0
|
作者：
Petropoulos, Konstantin
Maaske, Andre
Kirchhammer, Nicole
Festag, Julia
Buchi, Melanie
Michel, Sven
Zippelius, Alfred
Klar, Richard
Jaschinski, Frank
机构：
[1] Secarna Pharmaceut, Planegg Martinsried, Germany
[2] Univ Basel, Dept Biomed, Basel, Switzerland
[3] Univ Hosp Basel, Basel, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14592
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Dimitrios Mathios
    Jacob Ruzevick
    Christopher M. Jackson
    Haiying Xu
    Sagar Shah
    Janis M. Taube
    Peter C. Burger
    Edward F. McCarthy
    Alfredo Quinones-Hinojosa
    Drew M. Pardoll
    Michael Lim
    Journal of Neuro-Oncology, 2015, 121 : 251 - 259
  • [32] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Mathios, Dimitrios
    Ruzevick, Jacob
    Jackson, Christopher M.
    Xu, Haiying
    Shah, Sagar
    Taube, Janis M.
    Burger, Peter C.
    McCarthy, Edward F.
    Quinones-Hinojosa, Alfredo
    Pardoll, Drew M.
    Lim, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 251 - 259
  • [33] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
    Lilo, Mohammed
    Berry, Sneha
    Xu, Haiying
    Ogurtsova, Aleksandra
    Lipson, Evan
    Taube, Janis
    MODERN PATHOLOGY, 2015, 28 : 123A - 123A
  • [34] Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
    Mengling Wu
    Qianrui Huang
    Yao Xie
    Xuyi Wu
    Hongbo Ma
    Yiwen Zhang
    Yong Xia
    Journal of Hematology & Oncology, 15
  • [35] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
    Lilo, Mohammed
    Berry, Sneha
    Xu, Haiying
    Ogurtsova, Aleksandra
    Lipson, Evan
    Taube, Janis
    LABORATORY INVESTIGATION, 2015, 95 : 123A - 123A
  • [36] Clinical PD-1/PD-L1 Blockades in Combination Therapies for Lymphomas
    Katsuya, Hiroo
    Suzumiya, Junji
    Kimura, Shinya
    CANCERS, 2023, 15 (22)
  • [37] Oncolytic virus and PD-1/PD-L1 blockade combination therapy
    Chen, Chun-Yu
    Hutzen, Brian
    Wedekind, Mary F.
    Cripe, Timothy P.
    ONCOLYTIC VIROTHERAPY, 2018, 7 : 65 - 77
  • [38] Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
    Wu, Mengling
    Huang, Qianrui
    Xie, Yao
    Wu, Xuyi
    Ma, Hongbo
    Zhang, Yiwen
    Xia, Yong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [39] Programmed Death 1 (PD-1) and PD-1 Ligand (PD-L1) Expression in Chronic Apical Periodontitis
    Rezende Delgado, Ronan Jacques
    Ramos Pinheiro, Claudia
    Gasparoto, Thais Helena
    Sipert, Carla Renata
    de Moraes, Ivaldo Gomes
    Garcia, Roberto Brandao
    Bramante, Clovis Monteiro
    Bernardineli, Norberti
    Nishiyama, Celso Kenji
    da Silva, Joao Santana
    Torres, Sergio Aparecido
    Garlet, Gustavo Ponnpernnaier
    Campanelli, Ana Paula
    EUROPEAN ENDODONTIC JOURNAL, 2019, 4 (01): : 3 - 8
  • [40] Divergent Expression of PD-1 as Challenges and Chances of Immunotherapy Targeting PD-1 or PD-L1 in Cancer
    Huang, Haozhe
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 55 - 69
12345